CD42c Antibodies

Santa Cruz Biotechnology offers a broad range of CD42c monoclonal antibodies for investigating CD42c's role in various biological processes. CD42c monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD42c, also known as platelet glycoprotein VI, plays a critical role in platelet adhesion and aggregation, which are essential processes in hemostasis and thrombosis. By mediating interactions between platelets and the vascular endothelium, CD42c is vital for maintaining normal blood clotting mechanisms. Dysregulation of CD42c function can lead to various cardiovascular diseases, making it an important target for therapeutic interventions. CD42c monoclonal antibodies enable researchers to explore platelet function mechanisms and their implications in health and disease. Understanding CD42c's molecular pathways can provide crucial insights into cardiovascular disorders and potential treatment strategies. Research with CD42c monoclonal antibodies from Santa Cruz Biotechnology continues to advance scientific understanding of platelet biology and cardiovascular health.